Ligand validation:5PBD

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5PBD_EDO_A_2001	89%	82%	0.101	0.981	0.44	0.36	-	-	0	0	100%	0.45
5PBD_EDO_A_2002	8%	82%	0.219	0.698	0.53	0.27	-	-	0	0	100%	0.85
4IR5_EDO_A_2007	75%	81%	0.1	0.934	0.48	0.34	-	-	1	0	100%	1
5PDG_EDO_A_2001	73%	33%	0.111	0.939	1.73	0.96	1	-	0	0	100%	1
5PE8_EDO_A_2001	69%	35%	0.128	0.941	1.69	0.89	1	-	0	0	100%	1
5PFM_EDO_A_2001	67%	37%	0.118	0.927	1.74	0.74	1	-	0	0	100%	1
5PGC_EDO_A_2001	64%	18%	0.142	0.942	1.31	2.18	-	2	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.